SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-051065
Filing Date
2017-08-10
Accepted
2017-08-10 16:17:58
Documents
3
Period of Report
2017-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-20035_18k.htm 8-K 24354
2 EX-99.1 a17-20035_1ex99d1.htm EX-99.1 73395
3 GRAPHIC g200351mmi001.jpg GRAPHIC 5414
  Complete submission text file 0001104659-17-051065.txt   106493
Mailing Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713 919-806-4487
Dova Pharmaceuticals, Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38135 | Film No.: 171021671
SIC: 2834 Pharmaceutical Preparations